| 1 |
Beyond the NFAT Horizon: From Cyclosporine A-Induced Adverse Skin Effects to Novel Therapeutics |
|
| | Nathan J. Hawkshaw, Ralf Paus | | | Trends in Pharmacological Sciences. 2021; 42(5): 316 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation |
|
| | Carla Lloyd, Adam Arshad, Paloma Jara, Martin Burdelski, Bruno Gridelli, J. Manzanares, Michele Colledan, Emmanuel Jacquemin, Raymond Reding, Ulrich Baumann, Deirdre Kelly | | | Transplantation Direct. 2021; 7(10): e765 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
A new hypothesis to explain skin cancer risk in kidney allograft recipients |
|
| | Davide Viggiano, Michael W Lee, Mariadelina Simeoni, Giovambattista Capasso, Anna Capasso | | | Journal of Onco-Nephrology. 2021; 5(1): 3 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Cosmetically disfiguring side effects of cyclosporine A in an adolescent population |
|
| | Shamali Abeyagunawardena, ESK DeSilva, Asiri S Abeyagunawardena | | | Urology & Nephrology Open Access Journal. 2021; 9(1): 12 | | | [Pubmed] [Google Scholar] [DOI] | |
|
